IMC Bringing Israeli Expertise
Into a Global Market

A Pharma Grade Medical Cannabis Brand Capturing
The Full Value Chain at Higher Margins

Play Video

Financial Overview

$1,644.89 Feb 12, 2019
Valuation at IPO $52.7B
IPO Share Price CAD$4
Founded Date2010
FoundersOren Shuster & Rafael Gabay
Number of Employees50

Funding Rounds

2 Funding Rounds

C$ 29.5M Total Funding Amount



Total Investments Amount

Upcoming Events

CSE Reports

2019Annual Financial Statements 2019
q12019Quarterly Financial Statements Q1/2019
q22019Quarterly Financial Statements Q2/2019
See All Reports

Corporate Presentations

Corporate PresentationQ2 2020
See All Presentions

News and Updates

July 7, 2020

IMC Announces Business Update and Review of Q2 Milestones

June 25, 2020

IMC Announces Efficacy of IMC Branded Strains in Reducing Migraines

June 16, 2020

IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

View All News

Technology and Innovation

Our Technology Innovation

IMC is one of the world & the most advanced cannabis cultivators. Utilizing a decade of cannabis growing.....

Read More